Latest Medical Isotopes News

Energy Fuels Inc. reported a transformative 2024 with a major acquisition boosting its heavy mineral sands assets, a uranium production ramp-up at key US mines, and commercial rare earth oxide output from its White Mesa Mill.

Global Laser Enrichment has secured a US$98.9 million incentives package from Kentucky authorities to advance the Paducah Laser Enrichment Facility, marking a major milestone in the US nuclear fuel cycle. This support, alongside a US$28.5 million Department of Energy award, underlines the growing momentum behind Silex Systems’ laser uranium enrichment technology.

Anson Resources has delivered a high-purity lithium chloride sample to Nusano, marking a key step in testing and potential supply agreement discussions. Nusano’s evaluation could unlock new applications across energy and medical sectors.

Global Laser Enrichment, licensee of Silex’s laser uranium enrichment technology, has won a $28 million U.S. Department of Energy award to push next-gen nuclear fuel innovation, despite missing out on a larger $900 million contract.

Silex Systems announces that its exclusive licensee, Global Laser Enrichment, has achieved a critical technology milestone for its laser uranium enrichment process, enabling plans for a new US enrichment facility to advance.

Telix Pharmaceuticals reports a robust 53% revenue jump in Q3 2025 and raises its full-year guidance, underpinned by key reimbursement wins and expanding clinical programs.

Silex Systems Limited has announced a Share Purchase Plan (SPP) aiming to raise up to $15 million, offering existing eligible shareholders new shares at a price capped at $3.90 or a 2% discount to recent trading prices. This follows a $130 million institutional placement and supports key commercialisation projects in uranium enrichment.

Silex Systems Limited has announced a $145 million equity raise to fund the commercialisation of its SILEX laser uranium enrichment technology through its US joint venture, Global Laser Enrichment. The capital will support critical technology milestones and expansion into new isotope markets amid a global nuclear fuel renaissance.

Silex Systems has raised $130 million through an institutional placement to advance its SILEX uranium enrichment technology in the US, bolstering its financial position through FY2028.

ASPI Isotopes Inc. has agreed to acquire Renergen Limited in an all-share deal, creating a vertically integrated global entity focused on critical materials for semiconductors, medical isotopes, and green energy. The transaction addresses Renergen’s liquidity challenges and positions the combined company for growth across multiple strategic sectors.

Silex Systems reports steady progress on its TRL-6 uranium enrichment demonstration, targeting completion by end-2025, while securing initial US government funding to support commercialisation efforts.